BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20657078)

  • 1. Emergence of clindamycin-resistant Streptococcus pyogenes isolates obtained from patients with severe invasive infections in Japan.
    Ikebe T; Wada A; Oguro Y; Ogata K; Katsukawa C; Isobe J; Shima T; Suzuki R; Ohya H; Tominaga K; Okuno R; Uchitani Y; Watanabe H;
    Jpn J Infect Dis; 2010 Jul; 63(4):304-5. PubMed ID: 20657078
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections.
    Ikebe T; Hirasawa K; Suzuki R; Isobe J; Tanaka D; Katsukawa C; Kawahara R; Tomita M; Ogata K; Endoh M; Okuno R; Watanabe H
    Antimicrob Agents Chemother; 2005 Feb; 49(2):788-90. PubMed ID: 15673769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of fluoroquinolone-resistant Streptococcus pyogenes in Japan by a point mutation leading to a new amino acid substitution.
    Arai K; Hirakata Y; Yano H; Kanamori H; Endo S; Hirotani A; Abe Y; Nagasawa M; Kitagawa M; Aoyagi T; Hatta M; Yamada M; Nishimaki K; Takayama Y; Yamamoto N; Kunishima H; Kaku M
    J Antimicrob Chemother; 2011 Mar; 66(3):494-8. PubMed ID: 21172783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of macrolide resistance in Streptococcus pyogenes collected in Serbia.
    Pavlovic L; Grego E; Sipetic-Grujicic S
    Jpn J Infect Dis; 2010 Jul; 63(4):275-6. PubMed ID: 20657068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
    Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
    Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmid-Borne erm(T) from invasive, macrolide-resistant Streptococcus pyogenes strains.
    Woodbury RL; Klammer KA; Xiong Y; Bailiff T; Glennen A; Bartkus JM; Lynfield R; Van Beneden C; Beall BW;
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1140-3. PubMed ID: 18180360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types.
    Michos AG; Bakoula CG; Braoudaki M; Koutouzi FI; Roma ES; Pangalis A; Nikolopoulou G; Kirikou E; Syriopoulou VP
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):295-9. PubMed ID: 19395219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an erm(T) gene in strains of inducibly clindamycin-resistant group B Streptococcus.
    Dipersio LP; Dipersio JR
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):189-93. PubMed ID: 16989973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of tet(M), tet(O) and tet(S) in tetracycline/minocycline-resistant Streptococcus pyogenes bacteraemia isolates.
    Hammerum AM; Nielsen HU; Agersø Y; Ekelund K; Frimodt-Moller N
    J Antimicrob Chemother; 2004 Jan; 53(1):118-9. PubMed ID: 14657081
    [No Abstract]   [Full Text] [Related]  

  • 10. [Susceptibility of Streptococcus pyogenes isolates from pharyngeal exudates in Cordoba (Spain)].
    Gordillo RM; Lacasa MJ; Ibarra A; Rodríguez F; Casal M
    Rev Esp Quimioter; 2003 Mar; 16(1):58-60. PubMed ID: 12750758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A).
    Malhotra-Kumar S; Mazzariol A; Van Heirstraeten L; Lammens C; de Rijk P; Cornaglia G; Goossens H
    J Antimicrob Chemother; 2009 Jan; 63(1):42-6. PubMed ID: 18952616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008).
    Ardanuy C; Domenech A; Rolo D; Calatayud L; Tubau F; Ayats J; Martín R; Liñares J
    J Antimicrob Chemother; 2010 Apr; 65(4):634-43. PubMed ID: 20118164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of erythromycin- and clindamycin-resistant Streptococcus pyogenes emm 90 strains in Hawaii.
    Chen I; Kaufisi P; Erdem G
    J Clin Microbiol; 2011 Jan; 49(1):439-41. PubMed ID: 21068284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly virulent M1 Streptococcus pyogenes isolates resistant to clindamycin.
    Plainvert C; Martin C; Loubinoux J; Touak G; Dmytruk N; Collobert G; Fouet A; Ploy MC; Poyart C
    Med Mal Infect; 2015; 45(11-12):470-4. PubMed ID: 26602794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
    Rodríguez-Zurita ME; Solís del Baño S; Robres Guillén P; González Praetorius A; Gimeno Fernández C; Pérez Pomata MT; Bisquert Santiago J
    Rev Esp Quimioter; 2003 Mar; 16(1):61-4. PubMed ID: 12750759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Susceptibility of Streptococcus pyogenes to penicillin, macrolides and clindamycin in Cádiz].
    Marín P; Márquez A; García-Martos P; García-Tapia A; Tapia J
    Rev Esp Quimioter; 2000 Sep; 13(3):318-9. PubMed ID: 11086284
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
    Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ
    Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain.
    Garcia-Bermejo I; Cacho J; Orden B; Alós JI; Gómez-Garcés JL
    Antimicrob Agents Chemother; 1998 Apr; 42(4):989-90. PubMed ID: 9559831
    [No Abstract]   [Full Text] [Related]  

  • 19. Distribution of mef(A)-containing genetic elements in erythromycin-resistant isolates of Streptococcus pyogenes from Italy.
    D'Ercole S; Petrelli D; Prenna M; Zampaloni C; Catania MR; Ripa S; Vitali LA
    Clin Microbiol Infect; 2005 Nov; 11(11):927-30. PubMed ID: 16216111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrolide-resistant Streptococcus pyogenes in Central Greece: prevalence; mechanism and molecular identification.
    Malli E; Tatsidou E; Damani A; Pantelidi K; Petinaki E; Skoulakis C; Drougka E; Spiliopoulou I
    Int J Antimicrob Agents; 2010 Jun; 35(6):614-5. PubMed ID: 20206477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.